摘要
While foreign investors have been tied up with China＇s banks, the takeover deal of Harbin Pharmaceutical Holding Group suggests international buyout funds are at the same time looking for opportunities in different areas. An investor group led by New York-based Warburg Pincus LLC last year bought a 55 percents take in the drug maker based in northeastern China＇s Heilongjiang Province last year.Currently, the buyout fund and its partners arelooking to help Harbin Pharmaceutical Holding buy back publicly traded shares in its listed arm in order to move the drug maker forward in the Chinese pharmaceutical market. If the leverage buy out deal were to succeed, it would set another example for global investors clamoring for ashare of China＇s sizzling economy.
